Welcome to the official website of Huatong Fuyuan Biology
Tel: +86 538 8937 017 | Fax: +86 538 8937 017
Granulocyte stimulating factor (G-CSF)
Recombinant human serum albumin/granulocyte stimulating factor fusion protein for injection
Erythropoietin (EPO)
Recombinant human serum albumin/erythropoietin fusion protein for injection
Recombinant human serum albumin/granulocyte stimulating factor fusion protein
Streamlined production process, better stability and uniformity
Gene Recombinant Monoclonal Antibody Series Medical Injections
Used for the treatment of various diseases such as tumors and osteoporosis
Learn more about product information
Integrating the research and development, production, and sales of bio innovative drugs
TECHNICAL TEAM
Introduce international and domestic high-end pharmaceutical scientific research and other talents to promote the construction and operation of fuyuan Biotechnology Industrial Park
Ph.D. in Immunology, Wuhan Institute of Biological Products. He is the head of the biopharmaceutical project of Wuhan Institute of Biological Products, the director of the medical business center of Zhongzhu Medical Holdings Co., Ltd., and the chairman and general manager of Zhongzhu Laitai Pharmaceutical Co., Ltd. He has been engaged in R&D and production in the pharmaceutical industry for many years, and is familiar with the entire process of drug development from early stage R&D, clinical trials, registration application, industrialization and GMP production. As a senior position in a listed company, he has rich experience and executive power in R&D registration, equity investment, company operation, team management and comprehensive ability improvement of enterprise operation and management.
Peking University School of Medicine, Master of Pathogen Biology. He once served as the head of clinical and medical science in many listed companies such as Fosun Pharma, Hutchison Whampoa, and Hengrui Pharmaceuticals. He has extensive experience in medical strategy and action plan projects in many fields, especially in the field of innovative oncology drugs.
Chinese-American, microbiologist, postdoctoral fellow, and national-level foreign expert. One of the founders of the company. He has long been committed to the study of tumorigenesis mechanisms and original research on recombinant fusion protein innovative drugs, and has profound knowledge in the original research and industrialization of biological innovative drugs in China.
ABOUT
HUATONG FUYUAN BIOLOGY
Huatong Fuyuan Biopharmaceutical
A new type of pharmaceutical company integrating R&D, production and sales of bio-innovative drugs
Focus on the development of new projects in the field of biopharmaceuticals such as fusion proteins, monoclonal antibodies, and human vaccines, and gradually build Tai'an into a well-known biopharmaceutical research and development and production base in China, and build a biotechnology industry chain and industrial clusters.
Construction land
130 acres
Total surface area
150,000 square meters
Total planned investment
3 billion yuan
NEWS
Communication, start here